CD8A and neoplasm: This nanoparticle enhances tumor immunotherapy by disrupting mitochondrial function and activating CD4+ and CD8+ T cells, thereby increasing IL-2 and TNF-α expression, and significantly inhibiting tumor growth (Table 4) (Fig. 6) [146].